Newsroom

Utilizes ImmuKnow® immune monitoring assay to enhance transplant patient care.
Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex^TM, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. 

New Alpha-Gal IgE assay is the first to specifically detect antibodies associated with a delayed-onset allergic reaction to beef, pork, and lamb, the development of which has been linked to tick bites.

New testing service is the first to detect and measure deadly Invasive Pulmonary Aspergillosis